Global Transdermal Drug Patches Market Growth 2025-2031

Global Transdermal Drug Patches Market Growth 2025-2031

The global Transdermal Drug Patches market size is predicted to grow from US$ 6805 million in 2025 to US$ 7632 million in 2031; it is expected to grow at a CAGR of 1.9% from 2025 to 2031.

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Global key players of transdermal drug patches include Hisamitsu Pharmaceutical, Johnson & Johnson, Mylan, UCB Pharma, Novartis, etc. The top five players hold a share about 37%. North America is the largest market, has a share about 50%, followed by Europe and Asia-Pacific, both have a share about 24 percent.

LP Information, Inc. (LPI) ' newest research report, the “Transdermal Drug Patches Industry Forecast” looks at past sales and reviews total world Transdermal Drug Patches sales in 2024, providing a comprehensive analysis by region and market sector of projected Transdermal Drug Patches sales for 2025 through 2031. With Transdermal Drug Patches sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transdermal Drug Patches industry.

This Insight Report provides a comprehensive analysis of the global Transdermal Drug Patches landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transdermal Drug Patches portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transdermal Drug Patches market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transdermal Drug Patches and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transdermal Drug Patches.

This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Drug Patches market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Methyl Salicylate-based Patch
Rivastigmine Transdermal Patch
Fentanyl Transdermal Patch
Lidocaine Patch
Diclofenac Patch
Nicotine Transdermal Patch
Others

Segmentation by Application:
Rx Channel
OTC Channel

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Hisamitsu Pharmaceutical
Johnson & Johnson
Mylan
UCB Pharma
Novartis
Teva Pharmaceutical
Beijing Tide Pharmaceutical
Chattem
Nitto Denko
Grünenthal
Mundipharma
GSK
Luye Pharma Group
Bayer
IBSA Group
Dr Reddy’s Laboratories

Key Questions Addressed in this Report

What is the 10-year outlook for the global Transdermal Drug Patches market?

What factors are driving Transdermal Drug Patches market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Transdermal Drug Patches market opportunities vary by end market size?

How does Transdermal Drug Patches break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.